BRPI0910039A2 - métodos para aumento de absorção de peptídeos, peptidomiméticos, e outros substratos de proteína de transporte gastrointestinal - Google Patents

métodos para aumento de absorção de peptídeos, peptidomiméticos, e outros substratos de proteína de transporte gastrointestinal

Info

Publication number
BRPI0910039A2
BRPI0910039A2 BRPI0910039A BRPI0910039A BRPI0910039A2 BR PI0910039 A2 BRPI0910039 A2 BR PI0910039A2 BR PI0910039 A BRPI0910039 A BR PI0910039A BR PI0910039 A BRPI0910039 A BR PI0910039A BR PI0910039 A2 BRPI0910039 A2 BR PI0910039A2
Authority
BR
Brazil
Prior art keywords
peptidomimetics
peptides
methods
transport protein
protein substrates
Prior art date
Application number
BRPI0910039A
Other languages
English (en)
Inventor
Brian Michael Zanghi
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0910039A2 publication Critical patent/BRPI0910039A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
BRPI0910039A 2008-03-27 2009-03-26 métodos para aumento de absorção de peptídeos, peptidomiméticos, e outros substratos de proteína de transporte gastrointestinal BRPI0910039A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7206908P 2008-03-27 2008-03-27
PCT/US2009/001937 WO2009120378A2 (en) 2008-03-27 2009-03-26 Methods for increasing absorption of peptides, peptidomimetics, and other gastrointestinal transport protein substrates

Publications (1)

Publication Number Publication Date
BRPI0910039A2 true BRPI0910039A2 (pt) 2015-12-29

Family

ID=41114546

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0910039A BRPI0910039A2 (pt) 2008-03-27 2009-03-26 métodos para aumento de absorção de peptídeos, peptidomiméticos, e outros substratos de proteína de transporte gastrointestinal

Country Status (12)

Country Link
US (1) US8492331B2 (pt)
EP (1) EP2257287B1 (pt)
JP (1) JP5794911B2 (pt)
CN (2) CN102046169B (pt)
AU (1) AU2009229163B2 (pt)
BR (1) BRPI0910039A2 (pt)
CA (1) CA2719059C (pt)
ES (1) ES2703571T3 (pt)
MX (1) MX2010010569A (pt)
RU (1) RU2494737C2 (pt)
WO (1) WO2009120378A2 (pt)
ZA (1) ZA201007646B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2605454T3 (es) * 2011-06-08 2017-03-14 Nestec S.A. Métodos para reducir la neurodegeneración
AU2020345950A1 (en) 2019-09-11 2022-03-31 Prelude Therapeutics Incorporated CDK inhibitors and their use as pharmaceuticals
CN117598490A (zh) * 2023-12-14 2024-02-27 上海健力达生物科技有限公司 麦角硫因在制备胶原蛋白肽肠道吸收促进剂中的应用
CN120531715B (zh) * 2025-05-28 2026-03-17 中国人民解放军军事科学院军事医学研究院 大麻二酚在寡肽转运体抑制剂中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
CO4600681A1 (es) * 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria
JP2000143546A (ja) * 1998-11-16 2000-05-23 Hiroshi Wada メラトニンの酸化分解抑制剤
US6565879B1 (en) * 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
ATE406882T1 (de) * 2000-05-16 2008-09-15 Suntory Ltd Zusammensetzungen zur normalisierung des zirkadianen rythmus
JP2005523326A (ja) * 2002-04-22 2005-08-04 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ プロテインキナーゼｃのペプチドインヒビター
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
CN1925874B (zh) * 2002-12-09 2014-12-17 阿布拉西斯生物科学有限责任公司 组合物和传递药剂的方法
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
EP1696959A2 (en) * 2003-12-24 2006-09-06 Sepracor, Inc. Melatonin combination therapy for improving sleep quality
US20060257502A1 (en) * 2005-05-11 2006-11-16 Jiankang Liu A combination of mitochondrial nutrients for relieving stress, preventing and improving stress-related disorders
CN101138563A (zh) * 2005-12-09 2008-03-12 济南康泉医药科技有限公司 治疗消化性溃疡药物组合物
CN1814289A (zh) * 2005-12-09 2006-08-09 济南康泉医药科技有限公司 治疗消化性溃疡药物组合物
ITRM20070456A1 (it) * 2007-09-04 2009-03-05 Chronolife S R L Formulazione ad uso topico per la cura della cellulite.

Also Published As

Publication number Publication date
EP2257287A2 (en) 2010-12-08
CN103083643A (zh) 2013-05-08
WO2009120378A3 (en) 2009-12-30
JP5794911B2 (ja) 2015-10-14
US20110015117A1 (en) 2011-01-20
RU2494737C2 (ru) 2013-10-10
RU2010143877A (ru) 2012-05-10
CA2719059C (en) 2016-05-17
AU2009229163B2 (en) 2014-04-17
CN102046169B (zh) 2013-03-13
JP2011517449A (ja) 2011-06-09
EP2257287B1 (en) 2018-10-10
CN102046169A (zh) 2011-05-04
CA2719059A1 (en) 2009-10-01
ES2703571T3 (es) 2019-03-11
US8492331B2 (en) 2013-07-23
AU2009229163A1 (en) 2009-10-01
ZA201007646B (en) 2012-04-25
MX2010010569A (es) 2010-11-04
WO2009120378A2 (en) 2009-10-01
EP2257287A4 (en) 2011-05-18
CN103083643B (zh) 2015-01-07

Similar Documents

Publication Publication Date Title
HRP20160859T1 (hr) Modificirani proteini rsv f i postupci njihove upotrebe
DK2390265T3 (da) Insulinotropisk peptidderivat med modificeret N-terminal aminosyre
BRPI0909084A2 (pt) Composição líquida, e, composto de peptídeo.
BRPI0923199A2 (pt) métodos e composições para detecção de anticorpos com fixação de complemento.
BRPI0918122A2 (pt) molécula de diaboy, diaboy, e mólecula dart
PT2004155T (pt) Inibidores de agregação proteica
BRPI0812448A2 (pt) Método para aperfeiçoamento de propriedades de proteína
HUE039556T2 (hu) Emésztõenzim készítmény eclampsiára
HRP20151120T1 (xx) Polipeptid ace2
DK2117338T3 (da) Delvist hydrolyseret kornprotein
BRPI0819210A2 (pt) Anticorpos de proteína g anti-rsv
DK3118221T3 (da) Proteiner
HRP20170698T1 (hr) Lizosomski usmjereni peptidi i njihove uporabe
IL265409A (en) Antibodies and processes for preparing the same
DK2310034T3 (da) Peptider til behandling af beta-amyloidose
BRPI0915367A2 (pt) peptídeos e epítopos anti-p2x7
BRPI1014995A2 (pt) ligantes peptídeos para o isolamento e tratamento de células t autoimunes
EP2617715A4 (en) GLYCINTRANSPORTERHEMMER
DK2326638T5 (da) Diazepin- og diazocan-forbindelser som mc4-agonister
BRPI0917302A2 (pt) graos de arroz reconstituídos e processos para sua preparação
DE602009000650D1 (de) Probentransportsystem
EP2300033A4 (en) CONJUGATES OF COLLAGEN PEPTIDE AND USES THEREOF
DK2207790T3 (da) Biologisk aktive C-terminalt argininholdige peptider
EP2285827A4 (en) PEPTIDES AND THEIR USES
EP2296703A4 (en) IGF-II / IIE GF-BINDING PROTEIN

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL